Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Nausea × Taxes × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 10 Fallopian Tube Neoplasms 10 Breast Neoplasms 9 Carcinoma, Non-Small-Cell Lung 5 Brenner Tumor 5 Pancreatic Neoplasms 4 Endometrial Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Carcinoma 3 Uterine Cervical Neoplasms 2 Oropharyngeal Neoplasms 2 Neurotoxicity Syndromes 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Carcinosarcoma 2 Vomiting 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Recurrent Uterine Corpus Carcinoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Cancer Resectable 1 Pancreatic Adenocarcinoma 1 Pancreas Adenocarcinoma 1 Pain 1 Ovarian Germ Cell Cancer 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

Dexamethasone 12 Ondansetron 9 Granisetron 7 Palonosetron 5 Olanzapine 5 Aprepitant 5 casopitant 3 Radiotherapy 3 Prochlorperazine 2 Electroacupuncture 2 Analgesia 2 Acupressure 2 sinomenine 1 netupitant, palosentron drug combination 1 netupitant 1 lerisetron 1 fosaprepitant 1 dolasetron 1 dexamethasone acetate 1 Therapeutics 1 Thalidomide 1 Taxes 1 Surveys and Questionnaires 1 Sugars 1 Metoclopramide 1 Hygiene 1 Haloperidol 1 Gemcitabine 1 Exercise 1 Esomeprazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06017284 2023-11-24

PTCA199-5

Fudan University

Phase 3 Recruiting

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡